Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9UMS0: Variant p.Gly189Arg

NFU1 iron-sulfur cluster scaffold homolog, mitochondrial
Gene: NFU1
Feedback?
Variant information Variant position: help 189 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Arginine (R) at position 189 (G189R, p.Gly189Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In MMDS1; alters protein structure; increases likelihood of existing as monomer; decreases ability to receive a Fe/S clusters from donor proteins; decreases delivery rates of [2Fe-2S] cluster to target proteins. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 189 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 254 The length of the canonical sequence.
Location on the sequence: help VVAMIKELLDTRIRPTVQED G GDVIYKGFEDGIVQLKLQGS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         VVAMIKELLDTRIRPTVQEDGGDVIYKGFE--DGIVQLKLQGS

Mouse                         VVAMIKELLDTRIRPTVQEDGGDVIYRGFE--DGIVRLKLQ

Drosophila                    TVMMIKELLDTRIRPTVQEDGGDIVFMGYE--GGVVKLKMQ

Baker's yeast                 VSELIEELIDTRIRPAILEDGGDIDYRGWDPKTGTVYLRLQ
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 10 – 254 NFU1 iron-sulfur cluster scaffold homolog, mitochondrial
Region 173 – 241 NifU
Mutagenesis 189 – 189 G -> A. Alters protein structure. Increases likelihood of existing as monomer. Decreases ability to receive a Fe/S clusters from donor proteins. Decreases delivery rates of [2Fe-2S] cluster to target proteins.
Mutagenesis 189 – 189 G -> K. Alters protein structure. Increases likelihood of existing as monomer. Decreases ability to receive a Fe/S clusters from donor proteins. Decreases delivery rates of [2Fe-2S] cluster to target proteins.



Literature citations
Clinical, biochemical, and genetic spectrum of seven patients with NFU1 deficiency.
Ahting U.; Mayr J.A.; Vanlander A.V.; Hardy S.A.; Santra S.; Makowski C.; Alston C.L.; Zimmermann F.A.; Abela L.; Plecko B.; Rohrbach M.; Spranger S.; Seneca S.; Rolinski B.; Hagendorff A.; Hempel M.; Sperl W.; Meitinger T.; Smet J.; Taylor R.W.; Van Coster R.; Freisinger P.; Prokisch H.; Haack T.B.;
Front. Genet. 6:123-123(2015)
Cited for: VARIANTS MMDS1 PRO-21; TRP-182; ARG-189; ARG-190 AND CYS-208; CHARACTERIZATION OF VARIANTS MMDS1 PRO-21; TRP-182 AND CYS-208; Understanding the molecular basis for multiple mitochondrial dysfunctions syndrome 1 (MMDS1): impact of a disease-causing Gly189Arg substitution on NFU1.
Wesley N.A.; Wachnowsky C.; Fidai I.; Cowan J.A.;
FEBS J. 284:3838-3848(2017)
Cited for: VARIANT MMDS1 ARG-189; CHARACTERIZATION OF VARIANT MMDS1 ARG-189; MUTAGENESIS OF GLY-189; FUNCTION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.